Transenterix Inc (NYSEAMERICAN:TRXC) was down 9% on Tuesday . The stock traded as low as $2.12 and last traded at $2.13. Approximately 3,993,300 shares changed hands during mid-day trading, an increase of 23% from the average daily volume of 3,250,464 shares. The stock had previously closed at $2.34.

Several equities research analysts recently weighed in on TRXC shares. Zacks Investment Research lowered Transenterix from a “buy” rating to a “sell” rating in a report on Tuesday, August 8th. Ladenburg Thalmann Financial Services set a $5.00 target price on Transenterix and gave the company a “buy” rating in a report on Friday, October 20th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $4.00 target price (up previously from $3.75) on shares of Transenterix in a report on Monday, October 30th. One research analyst has rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $2.61.

In other news, CFO Joseph P. Slattery sold 333,000 shares of the company’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $2.93, for a total transaction of $975,690.00. Following the transaction, the chief financial officer now directly owns 440,974 shares of the company’s stock, valued at $1,292,053.82. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Joseph P. Slattery sold 529,609 shares of the company’s stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $2.80, for a total value of $1,482,905.20. Following the transaction, the chief financial officer now directly owns 440,974 shares in the company, valued at $1,234,727.20. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,462,609 shares of company stock worth $4,666,595.

A hedge fund recently raised its stake in Transenterix stock. Ladenburg Thalmann Financial Services Inc. raised its position in shares of Transenterix Inc (NYSEAMERICAN:TRXC) by 87.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 79,150 shares of the medical instruments supplier’s stock after buying an additional 37,000 shares during the quarter. Ladenburg Thalmann Financial Services Inc. owned about 0.05% of Transenterix worth $113,000 as of its most recent SEC filing.

ILLEGAL ACTIVITY NOTICE: “Transenterix (TRXC) Trading Down 9%” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/12/05/transenterix-trxc-trading-down-9.html.

About Transenterix

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.

Receive News & Stock Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related stocks with our FREE daily email newsletter.